DE69629230D1
(de)
*
|
1995-03-24 |
2003-09-04 |
Ocular Res Of Bonton Inc |
Hydrogellinse mit Lipid-Vorbeschichtigung
|
JPH10218760A
(ja)
*
|
1997-02-04 |
1998-08-18 |
Nobel Igaku Kenkyusho:Kk |
ドライアイ治療用の微量油添加目薬
|
EP0982025A1
(en)
*
|
1998-08-28 |
2000-03-01 |
Wilhelm Prof. Dr. Stoffel |
Synthetic tear fluid
|
ES2255987T3
(es)
|
1999-03-01 |
2006-07-16 |
Milcin Therapeutics Llc |
Preparaciones oftalmicas conteniendo mucina.
|
AUPQ228199A0
(en)
*
|
1999-08-18 |
1999-09-09 |
Sly, Anthony William |
Ophthalmic fluid
|
CN1387504A
(zh)
|
1999-11-09 |
2002-12-25 |
爱尔康公司 |
ω-链改性的15-羟基二十碳四烯酸衍生物和它们用于治疗干眼病的方法
|
US6552084B2
(en)
|
1999-11-09 |
2003-04-22 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
TR200201250T2
(tr)
|
1999-11-09 |
2002-09-23 |
Alcon, Inc |
Hidroksieikosatetraenoat tuzları, bileşimleri ve bunların göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri.
|
US6803385B2
(en)
|
1999-11-09 |
2004-10-12 |
Alcon, Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
US6320062B1
(en)
|
1999-11-09 |
2001-11-20 |
Alcon Universal Ltd. |
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
|
ATE258791T1
(de)
|
1999-11-09 |
2004-02-15 |
Alcon Inc |
Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
|
AU1101301A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
|
DE60020591T2
(de)
|
1999-11-09 |
2005-11-10 |
Alcon Inc. |
Benzenoidderivate von 15-hydroxyeicosatetraesäure und verfahren zur verwendung zur behandlung des trockenen auges
|
US6458854B2
(en)
|
1999-11-09 |
2002-10-01 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
AU776146B2
(en)
|
1999-11-09 |
2004-08-26 |
Alcon Inc. |
3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use
|
US6353032B1
(en)
|
1999-11-09 |
2002-03-05 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
TR200201249T2
(tr)
|
1999-11-09 |
2002-09-23 |
Alcon, Inc. |
15-hidroksieikosatetraenoik asitin heteroatomun araya girdiği analogları ve bunların kullanım yöntemleri.
|
MXPA02004700A
(es)
|
1999-11-09 |
2004-09-10 |
Alcon Inc |
Compuestos relacionados con acido 15-hidroxieicosatetraenoico y metodos de uso.
|
PL355998A1
(en)
|
1999-11-09 |
2004-05-31 |
Alcon Inc. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
CN1509462A
(zh)
|
2001-05-21 |
2004-06-30 |
|
NF-κB抑制剂在治疗干眼疾病中的用途
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
PT1392355E
(pt)
|
2001-05-21 |
2007-03-30 |
Alcon Inc |
Utilização de inibidores do proteassoma para tratar distúrbios associados à secura ocular
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
US6750250B1
(en)
|
2001-07-12 |
2004-06-15 |
Alcon, Inc. |
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
|
WO2003026687A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Nutraceutix, Inc. |
Delivery system for biological component
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
US20030109508A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Alcon, Inc. |
Methods for treating dry eye
|
BR0213179A
(pt)
*
|
2001-10-11 |
2004-09-14 |
Alcon Inc |
Métodos para tratamento de olhos secos por uma combinação de um esteróide antiinflamatório e um secretagogo de muc-1
|
US6656460B2
(en)
|
2001-11-01 |
2003-12-02 |
Yissum Research Development |
Method and composition for dry eye treatment
|
WO2004026406A1
(en)
*
|
2002-09-20 |
2004-04-01 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
BR0306662A
(pt)
*
|
2002-10-18 |
2005-02-22 |
Joel S Echols |
Formulação lacrimal de três camadas
|
US7051156B2
(en)
|
2002-11-06 |
2006-05-23 |
Synology Inc. |
Raid-5 disk having cache memory
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
AU2003303623A1
(en)
*
|
2002-12-20 |
2004-07-29 |
Alcon, Inc. |
Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
US20040137068A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Rajiv Bhushan |
Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye
|
WO2004093878A1
(en)
|
2003-04-16 |
2004-11-04 |
Alcon, Inc. |
Use of fused pyridazine derivatives for treating dry eye disorders
|
WO2005067892A1
(en)
*
|
2004-01-10 |
2005-07-28 |
Biolipid, Inc. |
Lipid compositions and methods of use
|
US20050182039A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Bausch & Lomb Incorporated |
Use of Loteprednol etabonate for the treatment of dry eye
|
US20050202097A1
(en)
*
|
2004-03-12 |
2005-09-15 |
Melbj Holdings, Llc, Florida |
Lubricant for the ocular surface
|
WO2006004577A2
(en)
*
|
2004-03-12 |
2006-01-12 |
Melbj Holdings, Llc |
Lubricant for the ocular surface
|
US8455016B2
(en)
|
2004-03-12 |
2013-06-04 |
Melbj Holdings, Llc |
Treatment for meibomian gland dysfunction or obstruction
|
WO2005094836A2
(en)
|
2004-03-25 |
2005-10-13 |
Bausch & Lomb Incorporated |
Use of loteprednol etabonate for the treatment of dry eye
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
PT1744736E
(pt)
*
|
2004-05-14 |
2010-01-05 |
Alcon Inc |
Método de tratamento de distúrbios do olho seco e uveíte
|
NZ552481A
(en)
*
|
2004-07-01 |
2008-12-24 |
Schepens Eye Res |
Compositions and methods for treating eye disorders and conditions
|
WO2006009101A1
(ja)
*
|
2004-07-21 |
2006-01-26 |
Senju Pharmaceutical Co, .Ltd. |
コンタクトレンズ用装着液
|
US7223737B1
(en)
|
2004-08-13 |
2007-05-29 |
Alcon, Inc. |
Method of treating dry eye disorders using glycosides
|
MX2007002400A
(es)
|
2004-08-27 |
2007-05-04 |
Senju Pharma Co |
Liquido para lavado de ojos para terapia de ojos secos.
|
WO2006065916A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(s)-hode and its analogs
|
EP2471530B1
(en)
|
2005-06-01 |
2017-01-11 |
Edison Pharmaceuticals, Inc. |
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
JP2009501725A
(ja)
*
|
2005-07-15 |
2009-01-22 |
チャクシュ・リサーチ・インコーポレーテッド |
糖尿病の眼科合併症の予防及び治療
|
WO2007058935A2
(en)
*
|
2005-11-14 |
2007-05-24 |
Bausch & Lomb Incorporated |
Ophthalmic composition for dry eye therapy
|
JP5374162B2
(ja)
|
2006-02-22 |
2013-12-25 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
|
US7745461B1
(en)
|
2006-02-27 |
2010-06-29 |
Alcon Research, Ltd. |
Method of treating dry eye disorders
|
ES2284398B2
(es)
|
2006-04-27 |
2008-12-16 |
Universidad Complutense De Madrid |
Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
|
US7691811B2
(en)
*
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
MX2008015151A
(es)
*
|
2006-07-07 |
2008-12-12 |
Bausch & Lomb |
Composiciones que comprenden un agonista del receptor glucocorticoide disociado y un agente inmunodepresor para tratar xeroftalmia.
|
US20080057022A1
(en)
*
|
2006-08-30 |
2008-03-06 |
Erning Xia |
Ophthalmic Pharmaceutical Compositions and Uses Thereof
|
WO2008052031A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Alcon Research, Ltd. |
2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
|
WO2008052037A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Alcon Research, Ltd. |
Packaging materials for formulations containing 2-pyrrolidone derivatives
|
US20080188573A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Alcon Research, Ltd. |
Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
|
WO2008154129A1
(en)
*
|
2007-06-08 |
2008-12-18 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
|
ITPD20070208A1
(it)
*
|
2007-06-19 |
2008-12-20 |
Alessandro Filippo |
Metodo di umidificazione di una lente a contatto
|
US7758190B2
(en)
*
|
2007-06-20 |
2010-07-20 |
Tearscience, Inc. |
Tear film measurement
|
US8192026B2
(en)
|
2007-06-20 |
2012-06-05 |
Tearscience, Inc. |
Tear film measurement
|
US20110130457A1
(en)
*
|
2008-08-06 |
2011-06-02 |
University Of Louisville Research Foundation, Inc. |
Wax-Based Emulsion for the Treatment of Dry Eye Conditions
|
CA2736250C
(en)
|
2008-09-10 |
2016-12-20 |
Edison Pharmaceuticals, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
US8539938B2
(en)
*
|
2009-03-12 |
2013-09-24 |
Ford Global Technologies, Llc |
Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
|
MY176503A
(en)
|
2009-03-26 |
2020-08-12 |
Biofermin Pharmaceutical Co Ltd |
Hypoglycemic effect enhancer
|
US9888839B2
(en)
|
2009-04-01 |
2018-02-13 |
Tearscience, Inc. |
Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms
|
EP2413699B1
(en)
|
2009-04-01 |
2019-11-20 |
Tearscience, Inc. |
Ocular surface interferometry (osi) apparatus for imaging an ocular tear film
|
US9642520B2
(en)
|
2009-04-01 |
2017-05-09 |
Tearscience, Inc. |
Background reduction apparatuses and methods of ocular surface interferometry (OSI) employing polarization for imaging, processing, and/or displaying an ocular tear film
|
PL2424495T3
(pl)
|
2009-04-28 |
2018-06-29 |
Bioelectron Technology Corporation |
Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
|
TWI478730B
(zh)
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
US9161531B2
(en)
|
2011-02-23 |
2015-10-20 |
Donald R. Korb |
High alcohol content sanitizer
|
US8859525B2
(en)
|
2011-07-19 |
2014-10-14 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
|
WO2013043387A1
(en)
|
2011-09-22 |
2013-03-28 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
US9339177B2
(en)
|
2012-12-21 |
2016-05-17 |
Tearscience, Inc. |
Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
|
ES2901406T3
(es)
|
2013-05-03 |
2022-03-22 |
Tearscience Inc |
Sistemas y métodos de iluminación de párpados para imagenología de las glándulas de Meibomio para análisis de las glándulas de Meibomio
|
US9795290B2
(en)
|
2013-11-15 |
2017-10-24 |
Tearscience, Inc. |
Ocular tear film peak detection and stabilization detection systems and methods for determining tear film layer characteristics
|
EP3117210A4
(en)
|
2014-03-12 |
2017-11-01 |
University Of Virginia Patent Foundation |
Compositions and methods for treating eye infections and disease
|
US9505709B2
(en)
|
2014-05-05 |
2016-11-29 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
MX2016016830A
(es)
|
2014-06-18 |
2017-07-07 |
Thetis Pharmaceuticals Llc |
Complejos de aminoacidos minerales de agentes activos.
|
EP3370718B1
(en)
|
2015-11-05 |
2021-01-27 |
University Of Louisville Research Foundation, Inc. |
Local and regional anesthesia and analgesia
|
GB201522144D0
(en)
*
|
2015-12-15 |
2016-01-27 |
Univ Manchester |
Compositions and uses and methods relating thereto
|
CN113024369A
(zh)
|
2015-12-17 |
2021-06-25 |
Ptc医疗公司 |
用于治疗氧化应急障碍的化合物
|
KR102437682B1
(ko)
|
2016-06-03 |
2022-08-29 |
테티스 파마수티컬스 엘엘씨 |
특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
|
TW201938141A
(zh)
|
2018-02-21 |
2019-10-01 |
瑞士商諾華公司 |
基於脂質的眼用乳劑
|
US11318066B2
(en)
|
2018-02-26 |
2022-05-03 |
Olympic Ophthalmics, Inc. |
Handheld device with vibrational cantilever member for treatment of disorders
|
WO2019231853A1
(en)
*
|
2018-06-01 |
2019-12-05 |
Aurora Tears Technology, Inc. |
Systems and methods for generating and applying biomimicry tear films
|
US11253395B2
(en)
|
2018-06-01 |
2022-02-22 |
Aurora Tears Technology, Inc. |
Systems and methods for generating and applying biomimicry tear films
|
CN113423387A
(zh)
*
|
2018-12-10 |
2021-09-21 |
埃特娜蒂尔公司 |
提供持久眼部润滑的眼用制剂
|
US11213551B1
(en)
|
2021-04-05 |
2022-01-04 |
Korb Research, Llc. |
Ocular treatment compositions and methods of use thereof
|
US20230028881A1
(en)
*
|
2021-07-21 |
2023-01-26 |
Meibomian Solutions LLC |
Eye lubricant
|
US11471475B1
(en)
|
2022-03-08 |
2022-10-18 |
Ralph P. Stone |
Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
|
US11679078B1
(en)
|
2022-03-08 |
2023-06-20 |
EternaTear, Inc. |
Ophthalmic formulations and related methods
|